GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is currently emerging as a prominent focus in medical studies, largely due to its impressive impact on treating conditions such as second type diabetes and obesity. New studies have shown that in addition to glucose regulation, GLP-1 medications offer potential for heart well-being and pos